Three months after its July 2022 debut on the Nasdaq, FaZe Holdings Inc. threw an exclusive party at

Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Diablo 4 Season 1 comes out in mid to late July with new gameplay features, challenges, Legendary Items, and Battle Pass.

(Reuters) -Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina and accused them of breaching their

Days after the US Supreme Court struck down race-conscious university admissions, civil rights groups have filed a federal lawsuit targeting so-called “legacy” admissions at Harvard University. The lawsuit, alleging widespread discrimination at the college in violation of the Civil Rights Act, is the latest challenge to the practice of prioritising university admissions for the children of alumni. “There’s no birthright to Harvard. As the Supreme Court recently noted, ‘eliminating racial discrimination means eliminating all of it.’ There should be no way to identify who your parents are in the college application process,” said Ivan Espinoza-Madrigal, executive director of Boston-based Lawyers for Civil Rights, which filed the complaint on 3 July. “Why are we rewarding children for privileges and advantages accrued by prior generations?” he said in a statement. “Your family’s last name and the size of your bank account are not a measure of merit, and should have no bearing on the college admissions process.” The group filed the lawsuit on behalf of the Chica Project, the African Community Economic Development of New England and the Greater Boston Latino Network. Last week, the conservative supermajority on the nation’s highest court ruled that private and public colleges and universities may not consider race as a factor in admissions, striking down the precedent affirmed in the 2003 ruling in Grutter v Bollinger. Civil rights advocates and justices who supported the decades-long precedent, intended to promote racially diverse college campuses, derided what they argue is the court’s ongoing perversion of the 14th Amendment and the foundational concept of equal protection. The latest lawsuit points to Harvard data finding that 70 per cent of the college’s donor-related and legacy applicants are white. So-called “legacy” applicants have a roughly six times greater chance of admission, according to records, pointing to a “custom, pattern and practice” that is “exclusionary and discriminatory” and “severely disadvantages and harms applicants of color,” plaintiffs argued. The complaint calls on the US Department of Education to initiate a federal investigation into Harvard’s application process and for the federal government to declare such practices illegal. “Harvard’s practice of giving a leg-up to the children of wealthy donors and alumni – who have done nothing to deserve it – must end,” Lawyers for Civil Rights litigation fellow Michael Kippins said in a statement accompanying the complaint. Following the Supreme Court ruling, Democratic lawmakers and President Joe Biden urged universities to reconsider their legacy admissions, which he said “expand privilege instead of opportunity.” The Independent has requested comment from Harvard. Read More Biden condemns Supreme Court striking down affirmative action: ‘This is not a normal court’ Biden reveals ‘new path’ to student debt relief after Supreme Court strikes down president’s plan Pence ‘doesn’t believe’ racial inequality exists in schools as he celebrates SCOTUS affirmative action ban

YouTube will soon introduce 30-second unskippable advertisements to its TV viewing experience. The company's top-performing

Tata Steel Ltd. says it won’t be able to achieve a goal to cut emissions by 2030 unless

A Southern California school board on Friday adopted a social studies curriculum that includes gay rights that was approved by parents and teachers after initially rejecting it.

OpenAI CEO Sam Altman is set to testify before a Senate Judiciary subcommittee on Tuesday after the viral success of ChatGPT, his company's chatbot tool, renewed an arms race over artificial intelligence and sparked concerns from some lawmakers about the risks posed by the technology.

SAVE 49%: ExpressVPN is the best service for accessing Max from anywhere in the world.

Santos Ltd., Australia’s second-biggest natural gas producer, wants to use carbon capture projects to store emissions for some

By Foo Yun Chee BRUSSELS (Reuters) -A majority of EU countries have rejected a push by Europe's big telecoms operators